Bugao, Lita L.
HRN: 02-15-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
MUPIROCIN 2%, 15G (TUBE)
03/29/2024
03/29/2024
CUTANEOUS
Apply To Affected Areas
Now
HD Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes